The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global In-Vitro Colorectal Cancer Screening Tests Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The In-Vitro Colorectal Cancer Screening Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global In-Vitro Colorectal Cancer Screening Tests market size is estimated to be worth US$ 1075.1 million in 2021 and is forecast to a readjusted size of USD 1539.6 million by 2028 with a CAGR of 5.3% during review period. Hospital and Clinics accounting for % of the In-Vitro Colorectal Cancer Screening Tests global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biomarker Tests segment is altered to a % CAGR between 2022 and 2028.
Global key companies of In-Vitro Colorectal Cancer Screening Tests include Alere(Abbott), Beckman Coulter, Siemens Healthcare, Eiken Chemical, and Hitachi Chemical (Kyowa Medex), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
In-Vitro Colorectal Cancer Screening Tests market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Biomarker Tests
Fecal Occult Blood Tests
CRC DNA Screening Tests
Market segment by Application, can be divided into
Hospital and Clinics
Ambulatory
Home Care
Market segment by players, this report covers
Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe In-Vitro Colorectal Cancer Screening Tests product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of In-Vitro Colorectal Cancer Screening Tests, with revenue, gross margin and global market share of In-Vitro Colorectal Cancer Screening Tests from 2019 to 2022.
Chapter 3, the In-Vitro Colorectal Cancer Screening Tests competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and In-Vitro Colorectal Cancer Screening Tests market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe In-Vitro Colorectal Cancer Screening Tests research findings and conclusion, appendix and data source.
Geographical Area
Global
The In-Vitro Colorectal Cancer Screening Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global In-Vitro Colorectal Cancer Screening Tests market size is estimated to be worth US$ 1075.1 million in 2021 and is forecast to a readjusted size of USD 1539.6 million by 2028 with a CAGR of 5.3% during review period. Hospital and Clinics accounting for % of the In-Vitro Colorectal Cancer Screening Tests global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Biomarker Tests segment is altered to a % CAGR between 2022 and 2028.
Global key companies of In-Vitro Colorectal Cancer Screening Tests include Alere(Abbott), Beckman Coulter, Siemens Healthcare, Eiken Chemical, and Hitachi Chemical (Kyowa Medex), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
In-Vitro Colorectal Cancer Screening Tests market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Biomarker Tests
Fecal Occult Blood Tests
CRC DNA Screening Tests
Market segment by Application, can be divided into
Hospital and Clinics
Ambulatory
Home Care
Market segment by players, this report covers
Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe In-Vitro Colorectal Cancer Screening Tests product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of In-Vitro Colorectal Cancer Screening Tests, with revenue, gross margin and global market share of In-Vitro Colorectal Cancer Screening Tests from 2019 to 2022.
Chapter 3, the In-Vitro Colorectal Cancer Screening Tests competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and In-Vitro Colorectal Cancer Screening Tests market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe In-Vitro Colorectal Cancer Screening Tests research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of In-Vitro Colorectal Cancer Screening Tests
1.2 Classification of In-Vitro Colorectal Cancer Screening Tests by Type
1.2.1 Overview: Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type in 2021
1.2.3 Biomarker Tests
1.2.4 Fecal Occult Blood Tests
1.2.5 CRC DNA Screening Tests
1.3 Global In-Vitro Colorectal Cancer Screening Tests Market by Application
1.3.1 Overview: Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital and Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Global In-Vitro Colorectal Cancer Screening Tests Market Size & Forecast
1.5 Global In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast by Region
1.5.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region, (2017-2022)
1.5.3 North America In-Vitro Colorectal Cancer Screening Tests Market Size and Prospect (2017-2028)
1.5.4 Europe In-Vitro Colorectal Cancer Screening Tests Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size and Prospect (2017-2028)
1.5.6 South America In-Vitro Colorectal Cancer Screening Tests Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 In-Vitro Colorectal Cancer Screening Tests Market Drivers
1.6.2 In-Vitro Colorectal Cancer Screening Tests Market Restraints
1.6.3 In-Vitro Colorectal Cancer Screening Tests Trends Analysis
2 Company Profiles
2.1 Alere(Abbott)
2.1.1 Alere(Abbott) Details
2.1.2 Alere(Abbott) Major Business
2.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product and Solutions
2.1.4 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Alere(Abbott) Recent Developments and Future Plans
2.2 Beckman Coulter
2.2.1 Beckman Coulter Details
2.2.2 Beckman Coulter Major Business
2.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product and Solutions
2.2.4 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Beckman Coulter Recent Developments and Future Plans
2.3 Siemens Healthcare
2.3.1 Siemens Healthcare Details
2.3.2 Siemens Healthcare Major Business
2.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product and Solutions
2.3.4 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Siemens Healthcare Recent Developments and Future Plans
2.4 Eiken Chemical
2.4.1 Eiken Chemical Details
2.4.2 Eiken Chemical Major Business
2.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product and Solutions
2.4.4 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Eiken Chemical Recent Developments and Future Plans
2.5 Hitachi Chemical (Kyowa Medex)
2.5.1 Hitachi Chemical (Kyowa Medex) Details
2.5.2 Hitachi Chemical (Kyowa Medex) Major Business
2.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product and Solutions
2.5.4 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Hitachi Chemical (Kyowa Medex) Recent Developments and Future Plans
2.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
2.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Details
2.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Major Business
2.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product and Solutions
2.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments and Future Plans
2.7 Sysmex
2.7.1 Sysmex Details
2.7.2 Sysmex Major Business
2.7.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Product and Solutions
2.7.4 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Sysmex Recent Developments and Future Plans
2.8 QIAGEN
2.8.1 QIAGEN Details
2.8.2 QIAGEN Major Business
2.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Product and Solutions
2.8.4 QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 QIAGEN Recent Developments and Future Plans
2.9 R-Biopharm
2.9.1 R-Biopharm Details
2.9.2 R-Biopharm Major Business
2.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product and Solutions
2.9.4 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 R-Biopharm Recent Developments and Future Plans
2.10 Immunostics
2.10.1 Immunostics Details
2.10.2 Immunostics Major Business
2.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Product and Solutions
2.10.4 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Immunostics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 In-Vitro Colorectal Cancer Screening Tests Players Market Share in 2021
3.2.2 Top 10 In-Vitro Colorectal Cancer Screening Tests Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 In-Vitro Colorectal Cancer Screening Tests Players Head Office, Products and Services Provided
3.4 In-Vitro Colorectal Cancer Screening Tests Mergers & Acquisitions
3.5 In-Vitro Colorectal Cancer Screening Tests New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue and Market Share by Type (2017-2022)
4.2 Global In-Vitro Colorectal Cancer Screening Tests Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2017-2022)
5.2 Global In-Vitro Colorectal Cancer Screening Tests Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2017-2028)
6.2 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2017-2028)
6.3 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country
6.3.1 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2017-2028)
6.3.2 United States In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
6.3.3 Canada In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
6.3.4 Mexico In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2017-2028)
7.2 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2017-2028)
7.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country
7.3.1 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2017-2028)
7.3.2 Germany In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
7.3.3 France In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
7.3.4 United Kingdom In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
7.3.5 Russia In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
7.3.6 Italy In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2017-2028)
8.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2017-2028)
8.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Region
8.3.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Region (2017-2028)
8.3.2 China In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
8.3.3 Japan In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
8.3.4 South Korea In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
8.3.5 India In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
8.3.7 Australia In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2017-2028)
9.2 South America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2017-2028)
9.3 South America In-Vitro Colorectal Cancer Screening Tests Market Size by Country
9.3.1 South America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2017-2028)
9.3.2 Brazil In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
9.3.3 Argentina In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2017-2028)
10.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2017-2028)
10.3 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country
10.3.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2017-2028)
10.3.2 Turkey In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
10.3.4 UAE In-Vitro Colorectal Cancer Screening Tests Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market In-Vitro Colorectal Cancer Screening Tests Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million) by Region (2017-2022)
Table 5. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Region (2023-2028)
Table 6. Alere(Abbott) Corporate Information, Head Office, and Major Competitors
Table 7. Alere(Abbott) Major Business
Table 8. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 9. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 11. Beckman Coulter Major Business
Table 12. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 13. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Siemens Healthcare Corporate Information, Head Office, and Major Competitors
Table 15. Siemens Healthcare Major Business
Table 16. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 17. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Eiken Chemical Corporate Information, Head Office, and Major Competitors
Table 19. Eiken Chemical Major Business
Table 20. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 21. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Hitachi Chemical (Kyowa Medex) Corporate Information, Head Office, and Major Competitors
Table 23. Hitachi Chemical (Kyowa Medex) Major Business
Table 24. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 25. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Clinical Genomics Pty Ltd (Quest Diagnostics) Corporate Information, Head Office, and Major Competitors
Table 27. Clinical Genomics Pty Ltd (Quest Diagnostics) Major Business
Table 28. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 29. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Sysmex Corporate Information, Head Office, and Major Competitors
Table 31. Sysmex Major Business
Table 32. Sysmex In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 33. Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 35. QIAGEN Major Business
Table 36. QIAGEN In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 37. QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. R-Biopharm Corporate Information, Head Office, and Major Competitors
Table 39. R-Biopharm Major Business
Table 40. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 41. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Immunostics Corporate Information, Head Office, and Major Competitors
Table 43. Immunostics Major Business
Table 44. Immunostics In-Vitro Colorectal Cancer Screening Tests Product and Solutions
Table 45. Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of In-Vitro Colorectal Cancer Screening Tests by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. In-Vitro Colorectal Cancer Screening Tests Players Head Office, Products and Services Provided
Table 50. In-Vitro Colorectal Cancer Screening Tests Mergers & Acquisitions in the Past Five Years
Table 51. In-Vitro Colorectal Cancer Screening Tests New Entrants and Expansion Plans
Table 52. Global In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million) by Type (2017-2022)
Table 53. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type (2017-2022)
Table 54. Global In-Vitro Colorectal Cancer Screening Tests Revenue Forecast by Type (2023-2028)
Table 55. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2017-2022)
Table 56. Global In-Vitro Colorectal Cancer Screening Tests Revenue Forecast by Application (2023-2028)
Table 57. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2017-2022) & (USD Million)
Table 58. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2023-2028) & (USD Million)
Table 59. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2017-2022) & (USD Million)
Table 60. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2023-2028) & (USD Million)
Table 61. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2017-2022) & (USD Million)
Table 62. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Region (2023-2028) & (USD Million)
Table 75. South America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2017-2022) & (USD Million)
Table 76. South America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2023-2028) & (USD Million)
Table 77. South America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2017-2022) & (USD Million)
Table 78. South America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2023-2028) & (USD Million)
Table 79. South America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2017-2022) & (USD Million)
Table 80. South America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. In-Vitro Colorectal Cancer Screening Tests Picture
Figure 2. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type in 2021
Figure 3. Biomarker Tests
Figure 4. Fecal Occult Blood Tests
Figure 5. CRC DNA Screening Tests
Figure 6. In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application in 2021
Figure 7. Hospital and Clinics Picture
Figure 8. Ambulatory Picture
Figure 9. Home Care Picture
Figure 10. Global In-Vitro Colorectal Cancer Screening Tests Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global In-Vitro Colorectal Cancer Screening Tests Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Region (2017-2028)
Figure 13. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Region in 2021
Figure 14. North America In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. In-Vitro Colorectal Cancer Screening Tests Market Drivers
Figure 20. In-Vitro Colorectal Cancer Screening Tests Market Restraints
Figure 21. In-Vitro Colorectal Cancer Screening Tests Market Trends
Figure 22. Alere(Abbott) Recent Developments and Future Plans
Figure 23. Beckman Coulter Recent Developments and Future Plans
Figure 24. Siemens Healthcare Recent Developments and Future Plans
Figure 25. Eiken Chemical Recent Developments and Future Plans
Figure 26. Hitachi Chemical (Kyowa Medex) Recent Developments and Future Plans
Figure 27. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments and Future Plans
Figure 28. Sysmex Recent Developments and Future Plans
Figure 29. QIAGEN Recent Developments and Future Plans
Figure 30. R-Biopharm Recent Developments and Future Plans
Figure 31. Immunostics Recent Developments and Future Plans
Figure 32. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Players in 2021
Figure 33. In-Vitro Colorectal Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players In-Vitro Colorectal Cancer Screening Tests Revenue Market Share in 2021
Figure 35. Global Top 10 Players In-Vitro Colorectal Cancer Screening Tests Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Type in 2021
Figure 38. Global In-Vitro Colorectal Cancer Screening Tests Market Share Forecast by Type (2023-2028)
Figure 39. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application in 2021
Figure 40. Global In-Vitro Colorectal Cancer Screening Tests Market Share Forecast by Application (2023-2028)
Figure 41. North America In-Vitro Colorectal Cancer Screening Tests Sales Market Share by Type (2017-2028)
Figure 42. North America In-Vitro Colorectal Cancer Screening Tests Sales Market Share by Application (2017-2028)
Figure 43. North America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Country (2017-2028)
Figure 44. United States In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe In-Vitro Colorectal Cancer Screening Tests Sales Market Share by Type (2017-2028)
Figure 48. Europe In-Vitro Colorectal Cancer Screening Tests Sales Market Share by Application (2017-2028)
Figure 49. Europe In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Country (2017-2028)
Figure 50. Germany In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Region (2017-2028)
Figure 58. China In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America In-Vitro Colorectal Cancer Screening Tests Sales Market Share by Type (2017-2028)
Figure 65. South America In-Vitro Colorectal Cancer Screening Tests Sales Market Share by Application (2017-2028)
Figure 66. South America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Country (2017-2028)
Figure 67. Brazil In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Country (2017-2028)
Figure 72. Turkey In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE In-Vitro Colorectal Cancer Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
